Skip to main content

Table 1 Characteristics of patients according to serum glucose levels at the time of hospital admission for an acute myocardial infarction

From: Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction

Characteristics

< 140 mg/dl (n = 1949)

≥ 140 mg/dl (n = 2191)

p-value

Age (median [IQR], years)

69 [57–81]

74 [63–82]

< 0.001

Age (%)

< 0.001

 < 55

20.7

11.9

 

 55–64

20.4

16.3

 

 65–74

20.2

23.9

 

 ≥ 75

38.8

48.0

 

Men (%)

62.0

54.4

< 0.001

White (%)

93.0

92.5

0.58

Medical history (%)

 Coronary artery disease

32.6

42.9

< 0.001

 Chronic lung disease

15.6

19.2

0.002

 Chronic kidney disease

16.5

24.3

< 0.001

 Diabetes

16.3

53.7

< 0.001

 Heart failure

17.1

28.1

< 0.001

 Hypertension

70.3

79.6

< 0.001

 Hypercholesterolemia

61.8

62.6

0.59

 Stable angina

13.9

15.3

0.23

 Stroke/transient ischemic attack

12.2

16.0

< 0.001

Findings at admission

 Pulse (median [IQR], beat/min)

78 [67–92]

88 [74–104]

< 0.001

 Systolic blood pressure (median [IQR], mmHg)

141 [122–161]

140 [119–161]

0.18

 Troponin I (median [IQR], ng/ml)

0.51 [0.10–3.50]

0.50 [0.10–3.70]

0.72

 Potassium (median [IQR], mmol/l)

4.1 [3.8–4.5]

4.2 [3.9–4.7]

< 0.001

 Calcium (median [IQR], mg/dl)

9.1 [8.7–9.5]

9.0 [8.7–9.4]

0.002

 WBCC (median [IQR], 109 cell/l)

8.9 [7.2–11.2]

10.4 [7.9–13.4]

< 0.001

ST segment elevation

29.8

31.8

0.16

In hospital complications (%)

 Acute kidney injury

10.4

19.3

< 0.001

 Atrial fibrillation

16.7

22.1

< 0.001

 Cardiogenic shock

2.4

6.5

< 0.001

 Heart failure

25.9

45.5

< 0.001

Treatment during hospitalization (%)

 Aspirin

94.4

91.6

< 0.001

 ACE-I/ARBs

67.7

73.3

< 0.001

 Antiarrhythmic agents

14.6

18.9

< 0.001

 Beta blockers

92.3

90.9

0.10

 Lipid lowering agents

77.2

74.1

0.018

 Thrombolytic therapy

2.3

2.4

0.74

 Percutaneous coronary intervention

51.6

42.0

< 0.001

 CABG

7.1

6.9

0.80

Length of stay (median [IQR], days)

4 [2–6]

4 [3–7]

< 0.001

  1. Italic values indicate significance of p value (p < 0.05)
  2. IQR interquartile range, WBCC white blood cell count, ACE-I/ARBs angiotensin converting enzyme inhibitor/angiotensin II receptor blockers, CABG coronary artery bypass graft surgery
  3. p-value from Chi square test and Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous variables
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840